INSIGHTS

We are very glad to announce Khurana & Khurana, Advocate and IP Attorneys (K&K) 's acquisition of Closer2Patents, a growing IP Consulting...

This article is relates to a recent judgment of Intellectual Property Appellate Board (hereinafter IPAB) dated 4 th  December 2014 in the...

Reportedly, a bench of Delhi High Court temporarily allowed Xiaomi to sell few of its devices in India about a week after the suspension...

Applicant in this case is M/s Air Master Equipments India (P) Ltd and Respondents are: Mr. Ramesh Nana Mhatre, who is the inventor and...

As reported in TOI , the Indian Government has found very little merit in Cipla’s plea for waiver and cancellation of Patent rights for...

In CS(OS)  3775/2014, as we understand from multiple sources, Xiaomi has been injuncted from manufacturing its line of smart phones for...

In a recent judgment, The U.S. Court of Appeals for the Federal Circuit on July 25, 2014, vacated the U.S. District Court's decision on...

We have earlier reported the release of Draft Guidelines for Examination of Pharma Patent Applications. The Patent office has now...

Two Days International Symposium for R&D Scientists and IP Practitioners We are happy to inform you all that IIPRD and Khurana & Khurana,...

With a significantly increasing number of Individual Inventors and Small/Medium Sized Clients regularly asking on Patent Registration...

Recently, Controller General of Patents Design and Trade Marks, Mr. Chaitanya Prasad,has issued a Public Notice on August 7, 2014,...

In a major setback, the Indian Patent Office denied a patent to an anti cancer drug Abraxane manufactured by US-Based Abraxis...

On June 12 th 2014, Elon Musk, CEO and Chief Product Architect of electric car company Tesla Motors announced that Tesla Motors will let...

As per the sources, the court in the Odisha capital, Bhuvaneshwar has admitted a petition challenging Aamir Khan Production’s plans to...

Manish Kumar, intern at Khurana and Khurana, Advocates and IP Attorneys, looks at ‘fee-shifting’ paradigm in US Patent Act in light of US...

Takshasheel Bouddha, an intern at Khurana and Khurana Advocates and IP Attorneys, analyses the case, M/s Aditi Manufacturing Company v/s...

There has been limited judicial consideration of how patent law applies to pharmaceutical inventions in India. Little specific guidance...

I really wonder if the Indian Patent Act was already less troublesome that we needed a new set of rules, substantially increased fees,...

The Patent (Amendment) Rules, 2014 has come in force with effective from 28th February 2014. The major changes are the hike in official...

This article relates to a judgment of Intellectual Property Appellate Board (hereinafter IPAB) dated 20 th January 2014 in the case “ ”...